文献速递心脑血管急症重症综合管理与镇静镇痛

早期启动口服降压药可缩短高血压性脑出血患者的ICU停留时间并降低住院费用

Early Initiation of Oral Antihypertensives Reduces Intensive Care Unit Stay and Hospital Cost for Patients with Hypertensive Intracerebral Hemorrhage.
PubMed 文献 · Neurocrit Care · 2020-01-01
一句话结论高血压性脑出血患者急诊到院24小时内启动口服降压药,与尼卡地平输注时间、ICU停留和住院费用显著降低相关,且不增加不良肾脏事件。

本研究为单中心回顾性研究,纳入2013年1月1日至2017年12月31日接受尼卡地平输注治疗的高血压性脑出血患者,按急诊到院24小时内(研究组90例)或24小时后(对照组76例)启动口服降压药分组。多因素回归校正混杂因素后,早期启动口服降压药与尼卡地平输注时间缩短(55.5±60.1 vs 121.6±141.3小时,p<0.005)、尼卡地平费用降低(14,207 vs 29,299美元,p<0.01)、ICU停留时间缩短(2 vs 5天,p<0.005)及住院费用降低(24,564 vs 47,366美元,p<0.01)相关。两组不良肾脏事件、良好功能结局及死亡率无显著差异。作者认为早期启动口服降压药安全,并可能对高血压性脑出血患者产生显著经济影响。

要点

  • 高血压性脑出血患者急诊到院24小时内启动口服降压药,与ICU停留时间缩短相关(2天 vs 5天,p<0.005)。
  • 早期启动口服降压药与尼卡地平输注时间缩短相关(55.5±60.1 vs 121.6±141.3小时,p<0.005)。
  • 早期启动口服降压药与住院费用降低相关(24,564 vs 47,366美元,p<0.01),尼卡地平费用亦降低(14,207 vs 29,299美元,p<0.01)。
  • 两组不良肾脏事件、良好功能结局及死亡率无显著差异。
  • 作者认为早期启动口服降压药安全,并可能对高血压性脑出血患者产生显著经济影响。

适用人群与场景

  • 2013年1月1日至2017年12月31日期间接受尼卡地平输注治疗的高血压性脑出血患者。
  • 按急诊到院24小时内(研究组)或24小时后(对照组)启动口服降压药分组。

研究设计与关键结果

  • 单中心回顾性研究,研究组90例、对照组76例;两组人口学特征、既往病史及初始收缩压无显著差异。
  • 多因素回归校正混杂因素后,早期启动口服降压药与尼卡地平输注时间缩短相关(55.5±60.1 vs 121.6±141.3小时,p<0.005)。
  • 早期启动口服降压药与尼卡地平费用降低相关(14,207 vs 29,299美元,p<0.01)。
  • 早期启动口服降压药与ICU停留时间缩短相关(2 vs 5天,p<0.005)。
  • 早期启动口服降压药与住院费用降低相关(24,564 vs 47,366美元,p<0.01)。
  • 两组不良肾脏事件、良好功能结局及死亡率无显著差异。

证据类型、等级与局限

  • 证据类型:单中心回顾性研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,对接受尼卡地平输注的高血压性脑出血患者,早期启动口服降压药安全,并可能产生显著经济影响。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND/OBJECTIVE: Intravenous nicardipine infusion is effective for rapid blood pressure control. However, its use requires hemodynamic monitoring in the intensive care unit (ICU) and is associated with high hospital cost. This study aimed to examine the effect of early versus late initiation of oral antihypertensives on ICU length of stay (LOS) and cost of hospitalization in patients with hypertensive intracerebral hemorrhage (ICH).

METHODS: This is a single-center retrospective study of patients with hypertensive ICH treated with nicardipine infusion from January 1, 2013, to December 31, 2017. Patients were dichotomized into study and control groups, based on receiving oral antihypertensives within 24 h versus after 24 h of emergency department arrival. Baseline characteristics, duration of nicardipine infusion, LOS in the ICU and hospital, functional outcome at discharge, and hospital cost were compared between the two groups using univariate and multivariate analysis.

RESULTS: A total of 90 patients in the study group and 76 in the control group were identified. There was no significant difference in demographics, past medical history, and initial SBP between the two groups. After adjusting for confounding factors with multivariate regression models, early initiation of oral antihypertensives was associated with significant reductions in duration of nicardipine infusion (55.5 ± 60.1 vs 121.6 ± 141.3 h, p <0.005), nicardipine cost ($14,207 vs $29,299, p < 0.01), ICU LOS (2 vs 5 days, p < 0.005), and cost of hospitalization ($24,564 vs $47,366, p < 0.01). There was no significant difference in adversary renal events, favorable outcomes, and mortality between the two groups.

CONCLUSIONS: Early initiation of oral antihypertensives is safe and may have a significant financial impact on patients with hypertensive ICH.

来源:Neurocrit Care,查看原文。版权归原作者所有。

参考来源

  1. Zhu Z, Bower M, Stern-Nezer S, et al. Early Initiation of Oral Antihypertensives Reduces Intensive Care Unit Stay and Hospital Cost for Patients with Hypertensive Intracerebral Hemorrhage. Neurocrit Care. 2020. PMID: 32253732. doi:10.1007/s12028-020-00951-1

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。